论文部分内容阅读
治疗爱滋病患者肺炎并发症的新药美普龙美普龙（Ａｔｏｖａｑｕｏｎｅ，Ｍｅｐｒｏｎ－惠康公司）已获ＦＤＡ批准，用于不能耐受甲氧苄氨嘧啶和复方新诺明的卡氏肺囊虫性肺炎（ＰＣＮ病人的适度治疗。卡氏肺囊虫性肺炎并发于７５％的爱滋病人，且是这些病人的致死原因。１...
Atovaquone (Mepron-Wellcome), a new drug used to treat complications of pneumonia in AIDS patients, has been approved by the FDA for piroxicothoracicosis that can not tolerate trimethoprim and cotrimoxazole Pneumonia (moderate treatment of PCN patients. Pneumocystis carinii pneumonia complicated by 75% of AIDS patients, and is the cause of death in these patients.